Vilija Lomeikaite

This study identifies distinct metabolic signatures in stable and progressive IPF/ILD by integrating HRCT scores with metabolomic profiling.

The paper identifies genetic modifiers of somatic CAG expansion and clinical phenotypes in Huntington's disease, revealing shared and tissue-specific effects on disease timing and pathogenic processes.